Get email alerts when RARE insiders make a move — free, no credit card

RARE Insider Trading & Form 4 Activity

Ultragenyx Pharmaceutical Inc.
Last filing: Jul 6, 2026·2 days ago
NEUTRAL · LAST 90 DAYS
0%
buyers
$0
0 buys
$59K
2 sells
-$59K
net selling
2
insiders
Tracking RARE insiders takes 3 seconds. Get free alerts →

Net flow — last 12 months

Monthly net of insider buys minus sells. Green months indicate net buying; red months indicate net selling.

Most active insiders

Ranked by total transaction value over the last 90 days.

INSIDERBOUGHTSOLDNET
Horn Howard
Chief Financial Officer
$266K
-$266K
Suliman Shehnaaz
Director
$144K
-$144K
Sanders Corazon (corsee) D.
Director
$50K
-$50K
Parschauer Karah Herdman
EVP and Chief Legal Officer
$47K
-$47K
Crombez Eric
EVP and Chief Medical Officer
$9K
-$9K
Ray Amrit
Director
$0
Narachi Michael
Director
$0
Fust Matthew K
Director
$0

Recent transactions

Every Form 4 transaction for RARE, newest first.

SELL10b5-1
Horn Howard · Chief Financial Officer
Tx Jul 1·Filed Jul 6·EDGAR ↗
4,698 sh @ $33.13
$156K
SELL10b5-1
Parschauer Karah Herdman · EVP and Chief Legal Officer
Tx Jun 15·Filed Jun 15·EDGAR ↗
1,899 sh @ $24.62
$47K
SELL
Sanders Corazon (corsee) D. · Director
Tx Jun 15·Filed Jun 15·EDGAR ↗
2,000 sh @ $25.05
$50K
SELL10b5-1
Horn Howard · Chief Financial Officer
Tx Jun 1·Filed Jun 1·EDGAR ↗
4,653 sh @ $23.77
$111K
SELL10b5-1
Suliman Shehnaaz · Director
Tx May 18·Filed May 18·EDGAR ↗
5,740 sh @ $25.12
$144K
AWARD
Sanders Corazon (corsee) D. · Director
Tx May 14·Filed May 18·EDGAR ↗
7,751 sh
AWARD
Ray Amrit · Director
Tx May 14·Filed May 18·EDGAR ↗
7,751 sh
AWARD
Narachi Michael · Director
Tx May 14·Filed May 18·EDGAR ↗
7,751 sh
AWARD10b5-1
Suliman Shehnaaz · Director
Tx May 14·Filed May 18·EDGAR ↗
7,751 sh
AWARD
Fust Matthew K · Director
Tx May 14·Filed May 18·EDGAR ↗
7,751 sh
AWARD
Welch Daniel G · Director
Tx May 14·Filed May 18·EDGAR ↗
7,751 sh
AWARD
Dunsire Deborah · Director
Tx May 14·Filed May 18·EDGAR ↗
7,751 sh
SELL
Crombez Eric · EVP and Chief Medical Officer
Tx May 5·Filed May 6·EDGAR ↗
344 sh @ $24.96
$9K

Track every ticker you care about

Free plan includes 3 tickers, daily insider scans, and cluster alerts. No credit card.

Start free (3 tickers)See plans

Join investors tracking SEC filings.

About RARE insider trading data

Form 4 is the SEC filing required when an officer, director, or 10% owner of a public company buys or sells the company's stock. By law, these filings must be submitted within two business days of the trade. Tracenotes pulls every Form 4 filing for RARE from EDGAR, parses it, and surfaces the activity on this page.

What insider buying tells you. Open-market purchases by insiders are widely studied as a meaningful signal. Unlike stock awards (which are compensation, not conviction), an executive spending their own money to buy shares of the company they run is a vote of confidence. Studies have found insider-buying clusters — three or more insiders buying within a short window — outperform the broader market over the following year.

What insider selling tells you. Selling is noisier. Many sales are pre-scheduled under SEC Rule 10b5-1 plans, which let insiders sell on a fixed schedule regardless of company news. We label these "10b5-1" so you can see them. Discretionary sales — sales not tied to a plan — are more meaningful, especially when multiple insiders sell in quick succession.

Tracenotes methodology. We scan EDGAR daily for new Form 4 filings, parse them into individual transactions, and detect clusters when three or more distinct insiders buy or sell within a 14-day window. The data on this page covers the last 12 months. For deeper analysis, Tracenotes also runs language-change detection on 10-K and 10-Q filings — that's our core product.

See this for every ticker.

Tracenotes covers the S&P 500 and beyond. Pick any ticker — get the same depth of insider trading data.

AAPLNVDAMSFTTSLA

Free plan available — no credit card. Sign up free →

Frequently asked questions

What is a Form 4 filing?

Form 4 is the SEC disclosure required when a company insider — an officer, director, or 10% owner — buys or sells the company's stock. By law these filings must be submitted within two business days of the trade.

Is insider buying RARE always bullish?

Open-market purchases by insiders are widely viewed as a bullish signal because executives are spending their own money. Stock awards and option exercises are part of compensation and don't carry the same weight, which is why we treat them separately on this page.

What is a 10b5-1 trade?

A trade made under SEC Rule 10b5-1, which lets insiders pre-schedule sales weeks or months in advance. These sales execute on a fixed plan regardless of company news, so they're a weaker signal than discretionary sales. We label them with a "10b5-1" tag.

What is an insider cluster?

A cluster is when three or more distinct insiders buy or sell within a 14-day window. Clusters are studied as stronger signals than single trades because multiple people independently reach the same view. We surface active clusters on Ultragenyx Pharmaceutical Inc. (RARE) when they form.

Where does RARE insider trading data come from?

Every Form 4 filing for RARE is sourced directly from SEC EDGAR. Tracenotes scans EDGAR daily, parses each Form 4 into individual transactions, and updates this page within hours of new filings.

Nothing on this page constitutes investment advice. Form 4 data is sourced from SEC EDGAR and provided for research purposes only.

© 2026 Tracenotes · tracenotes.ai